Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 23

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Pre-eclampsia: a Scoping Review of Risk Factors and Suggestions for Future Research Direction

Lee, Kiara, Brayboy, Lynae, Tripathi, Anubhav·2022·Regenerative Engineering and Translational Medicine
DOI 10.1007/s40883-021-00243-w
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40883-021-00243-w

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 118

  1. Cunningham FG, et al. “Hypertensive disorders”, in Williams Obstetrics, 25e, New York. NY: McGraw-Hill Education; 2018.
  2. Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin: gestational hypertension and preeclampsia. Obestet Gynecol. 2019;133(76):168–186.
  3. N. I. for H. and C. Excellence. Hypertension in pregnancy : diagnosis and management. Am J Obs. Gynecol. 2019;1:S1-s22. https://doi.org/10.1111/j.1479-828X.2009.01003.x. · DOI
  4. Brown MA, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Hypertension. 2018;13:291–310. https://doi.org/10.1016/j.preghy.2018.05.004. · DOI
  5. Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019;134–135:1–10. https://doi.org/10.1016/j.jri.2019.07.004. · DOI
  6. Wertaschnigg D, Reddy M, Mol BWJ, Rolnik DL, da Silva Costa F. Prenatal screening for pre-eclampsia: frequently asked questions. Aust New Zeal J Obstet Gynaecol. 2019;59(4):477–83. https://doi.org/10.1111/ajo.12982. · DOI
  7. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2018;112(2):359–72. · DOI
  8. Bramham K, Briley AL, Seed P, Poston L, Shennan AH, Chappell LC. Adverse maternal and perinatal outcomes in women with previous preeclampsia: A prospective study. Am J Obstet Gynecol. 2011;204(6):512.e1-512.e9. https://doi.org/10.1016/j.ajog.2011.02.014. · DOI
  9. Redman CWG, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213(4):S9.e1-S9.e4. https://doi.org/10.1016/j.ajog.2015.08.003. · DOI
  10. Tan MY, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol. 2018;52(1):52–9. https://doi.org/10.1002/uog.19077. · DOI
  11. Frederiksen LE, et al. Risk of adverse pregnancy outcomes at advanced maternal age. Obstet Gynecol. 2018;131(3):457–63. https://doi.org/10.1097/AOG.0000000000002504. · DOI
  12. Ndiaye K, Portillo E, Ouedraogo D, Mobley A, Babalola S. High-risk advanced maternal age and high parity pregnancy: tackling a neglected need through formative research and action. Glob Heal Sci Pract. 2018;6(2):370–80. https://doi.org/10.9745/GHSP-D-17-00417. · DOI
  13. Broekmans FJ, Knauff EAH, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends in Endocrinology and Metabolism, vol. 18, no. 2. Elsevier Current Trends, pp. 58–65, 2007. https://doi.org/10.1016/j.tem.2007.01.004. · DOI · Paper page
  14. Sultana Z, Maiti K, Dedman L, Smith R. Is there a role for placental senescence in the genesis of obstetric complications and fetal growth restriction? Am J Obstet Gynecol. 2018;218(2):S762–73. https://doi.org/10.1016/j.ajog.2017.11.567 (Mosby Inc.). · DOI
  15. Parra-Pingel PE, Quisiguiña-Avellán LA, Hidalgo L, Chedraui P, Pérez-López FR. Pregnancy outcomes in younger and older adolescent mothers with severe preeclampsia. Adolesc Health Med Ther. 2017;8:81–6. https://doi.org/10.2147/ahmt.s131050. · DOI
  16. Brosens I, et al. Adolescent preeclampsia: pathological drivers and clinical prevention. Reprod Sci. 2019;26(2):159–71. https://doi.org/10.1177/1933719118804412 (SAGE Publications Inc.). · DOI
  17. Luo ZC, An N, Xu HR, Larante A, Audibert F, Fraser WD. The effects and mechanisms of primiparity on the risk of pre-eclampsia: a systematic review. Paediatr Perinat Epidemiol. 2007;21(1):36–45. https://doi.org/10.1111/j.1365-3016.2007.00836.x. · DOI
  18. Redman CWG, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534–43. https://doi.org/10.1111/j.1600-0897.2010.00831.x. · DOI
  19. Robertson SA, Sharkey DJ. Seminal fluid and fertility in women. Fertil Steril. 2016;106(3):511–9. https://doi.org/10.1016/j.fertnstert.2016.07.1101. · DOI
  20. Thomopoulos C, et al. Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis. J Clin Hypertens. 2017;19(2):173–83. https://doi.org/10.1111/jch.12945. · DOI
  21. Jie Z, Yiling D, Ling Y. Association of assisted reproductive technology with adverse pregnancy outcomes. Iran J Reprod Med. 2015;13(3);169–180. https://www.pmc/articles/PMC4426157/?report=abstract. Accessed 03 Nov 2020.
  22. Almasi-Hashiani A, et al. Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19:1. https://doi.org/10.1186/s12884-019-2291-x (BioMed Central Ltd). · DOI
  23. Omani-Samani R, et al. Risk of preeclampsia following assisted reproductive technology: systematic review and meta-analysis of 72 cohort studies. J Matern Neonatal Med. 2020;33(16):2826–40. https://doi.org/10.1080/14767058.2018.1560406. · DOI
  24. Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens. 2013;27(3):148–57. https://doi.org/10.1038/jhh.2012.13. · DOI
  25. Liu K, et al. Advanced Reproductive Age and Fertility. J Obstet Gynaecol Canada. 2011;33(11):1165–75. https://doi.org/10.1016/S1701-2163(16)35087-3. · DOI
  26. Storgaard M, et al. Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol. 2017;124(4):561–72. https://doi.org/10.1111/1471-0528.14257. · DOI
  27. Choo SY. The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med J. 2007;48(1):11–23. https://doi.org/10.3349/ymj.2007.48.1.11. · DOI · Paper page
  28. Alecsandru D, et al. Parental human leukocyte antigen-C allotypes are predictive of live birth rate and risk of poor placentation in assisted reproductive treatment. Fertil Steril. 2020;114(4):809–17. https://doi.org/10.1016/j.fertnstert.2020.05.008. · DOI
  29. van Bentem K, et al. The development of preeclampsia in oocyte donation pregnancies is related to the number of fetal-maternal HLA class II mismatches. J Reprod Immunol. 2020;137:103074. https://doi.org/10.1016/j.jri.2019.103074. · DOI
  30. Sun LM, Walker MC, Cao HL, Yang Q, Duan T, Kingdom JCP. Assisted reproductive technology and placenta-mediated adverse pregnancy outcomes. Obstet Gynecol. 2009;114(4):818–24. https://doi.org/10.1097/AOG.0b013e3181b76bd1. · DOI
  31. Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol. 2003;1:111. https://doi.org/10.1186/1477-7827-1-111. · DOI
  32. Lateef A, Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am. 2017;43(2):215–26. https://doi.org/10.1016/j.rdc.2016.12.009. · DOI
  33. Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv. 2011;66(10):639–53. https://doi.org/10.1097/OGX.0b013e318239e1ee. · DOI
  34. Stolarczyk E. Adipose tissue inflammation in obesity. Curr Opin Pharmacol. 2017;37:35–40. https://doi.org/10.1016/j.coph.2017.08.006 (Elsevier Ltd). · DOI · Paper page
  35. Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017;356:1. https://doi.org/10.1136/bmj.j1 (BMJ Publishing Group). · DOI · Paper page
  36. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. 1998. https://doi.org/10.1016/S0002-9378(98)70160-7. · DOI
  37. Lumbers ER, Delforce SJ, Arthurs AL, Pringle KG. Causes and consequences of the dysregulated maternal renin-angiotensin system in preeclampsia. Front Endocrinol. 2019;10:563. https://doi.org/10.3389/fendo.2019.00563. · DOI
  38. Egeland GM, Klungsøyr K, Øyen N, Tell GS, Næss Ø, Skjærven R. Preconception cardiovascular risk factor differences between gestational hypertension and preeclampsia: cohort norway study. Hypertension. 2016;67(6):1173–80. https://doi.org/10.1161/HYPERTENSIONAHA.116.07099. · DOI
  39. Bokslag A, van Weissenbruch M, Mol BW, de Groot CJM. Preeclampsia; short and long-term consequences for mother and neonate. Early Hu Dev. 2016;102:47–50. https://doi.org/10.1016/j.earlhumdev.2016.09.007 (Elsevier Ireland Ltd). · DOI
  40. Pauli JM, Repke JT. Preeclampsia: short-term and Long-term Implications. Obstet Gynecol Clin North Am. 2015;42(2):299–313. https://doi.org/10.1016/j.ogc.2015.01.007 (W.B. Saunders). · DOI
  41. Jim B, Karumanchi SA. Preeclampsia: pathogenesis, prevention, and long-term complications. Semin Nephrol. 2017;37(4):386–97. https://doi.org/10.1016/j.semnephrol.2017.05.011. · DOI
  42. Williams D. Pre-eclampsia and long-term maternal health. Obstet Med. 2012;5(3):98–104. https://doi.org/10.1258/om.2012.120013. · DOI
  43. Lane-Cordova AD, Khan SS, Grobman WA, Greenland P, Shah SJ. Long-term cardiovascular risks associated with adverse pregnancy outcomes: JACC review topic of the week. J Am Coll Cardiol. 2019;73(16):2106–16. https://doi.org/10.1016/j.jacc.2018.12.092. · DOI
  44. Hawthorne G. Maternal complications in diabetic pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(1):77–90. https://doi.org/10.1016/j.bpobgyn.2010.10.015. · DOI
  45. Leguizamón G, Trigubo D, Pereira JI, Vera MF, Fernández JA. Vascular complications in the diabetic pregnancy. Curr Diabetes Rep. 2015;15(4):1–10. https://doi.org/10.1007/s11892-015-0586-5. · DOI
  46. Smith C, Teng F, Branch E, Chu S, Joseph KS. Maternal and perinatal morbidity and mortality associated with anemia in pregnancy. Obstet Gynecol. 2019;134(6):1234–44. https://doi.org/10.1097/AOG.0000000000003557. · DOI
  47. Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. BJOG An Int J Obstet Gynaecol. 1986;93(9):898–908. https://doi.org/10.1111/j.1471-0528.1986.tb08006.x. · DOI
  48. Nejatizadeh A, Stobdan T, Malhotra N, Pasha MAQ. The genetic aspects of pre-eclampsia: achievements and limitations. Biochem Genet. 2008;46(7–8):451–79. https://doi.org/10.1007/s10528-008-9163-9 (Springer). · DOI
  49. Graves JAM. Genomic imprinting, development and disease – is pre-eclampsia caused by a maternal imprinted gene? Reprod Fertil Dev. 1998;10:23–9. https://doi.org/10.1071/RD98014. · DOI
  50. Benny PA, Alakwaa FM, Schlueter RJ, Lassiter CB, Garmire LX. A review of omics approaches to study preeclampsia. Placenta. 2020;92:17–27. https://doi.org/10.1016/j.placenta.2020.01.008. · DOI
  51. Williams PJ, Broughton Pipkin F. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):405–17. https://doi.org/10.1016/j.bpobgyn.2011.02.007. · DOI · Paper page
  52. Flaskerud JH, Delilly CR. Social determinants of health status. Issues Ment Health Nurs. Jul. 2012;33(7):494–7. https://doi.org/10.3109/01612840.2012.662581. · DOI · Paper page
  53. Bibbins-Domingo K, et al. Screening for Preeclampsia US preventive services task force recommendation statement. J Am Med Assoc. 2017;317(16):1661–7. https://doi.org/10.1001/jama.2017.3439. · DOI
  54. Zhang M, et al. Preeclampsia among African American pregnant women. Obstet Gynecol Surv. 2020;75(2):111–20. https://doi.org/10.1097/OGX.0000000000000747. · DOI
  55. Ross KM, Guardino C, Dunkel Schetter C, Hobel CJ. Interactions between race/ethnicity, poverty status, and pregnancy cardio-metabolic diseases in prediction of postpartum cardio-metabolic health. Ethn Health. 2018;25:1–16. https://doi.org/10.1080/13557858.2018.1493433. · DOI
  56. Tanaka M, et al. Racial disparity in hypertensive disorders of pregnancy in New York state: a 10-year longitudinal population-based study. Am J Public Health. 2007;97(1):163–70. https://doi.org/10.2105/AJPH.2005.068577. · DOI
  57. Clowse MEB, Grotegut C. Racial and ethnic disparities in the pregnancies of women with systemic lupus erythematosus. Arthritis Care Res. 2016;68(10):1567–72. https://doi.org/10.1002/acr.22847. · DOI
  58. Barnado A, Wheless L, Meyer AK, Gilkeson GS, Kamen DL. Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls. Lupus Sci Med. 2014;1(1):20. https://doi.org/10.1136/lupus-2014-000020. · DOI
  59. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51(4 Part 2 Suppl):1002–9. https://doi.org/10.1161/HYPERTENSIONAHA.107.107565. · DOI
  60. Samadi AR, Mayberry RM, Zaidi AA, Pleasant JC, McGhee N, Rice RJ. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol. 1996;87(4):557–63. https://doi.org/10.1016/0029-7844(95)00480-7. · DOI
  61. Nguyen BT, Cheng YW, Snowden JM, Esakoff TF, Frias AE, Caughey AB. The effect of race/ethnicity on adverse perinatal outcomes among patients with gestational diabetes mellitus. Am J Obstet Gynecol. 2012;207(4):322.e1-322.e6. https://doi.org/10.1016/j.ajog.2012.06.049. · DOI
  62. James-Todd T, Janevic T, Brown FM, Savitz DA. Race/ethnicity, educational attainment, and pregnancy complications in New York City women with pre-existing diabetes. Paediatr Perinat Epidemiol. 2014;28(2):157–65. https://doi.org/10.1111/ppe.12100. · DOI
  63. Reidy KJ, et al. Fetal—not maternal—APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am J Hum Genet. 2018;103(3):367–76. https://doi.org/10.1016/j.ajhg.2018.08.002. · DOI
  64. Rouse DJ. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus: commentary. Obstet Gynecol Surv. 2006;61(2):78–9. https://doi.org/10.1097/01.ogx.0000197814.31769.3b. · DOI
  65. Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381. https://doi.org/10.1136/bmj.l2381. · DOI · Paper page
  66. Wu P, et al. Early pregnancy biomarkers in pre-eclampsia: a systematic review and meta-analysis. Int J Mol Sci. 2015;16(9):23035–56. https://doi.org/10.3390/ijms160923035. · DOI
  67. McCarthy FP, Ryan RM, Chappell LC. Prospective biomarkers in preterm preeclampsia: a review. Pregnancy Hypertens. 2018;14:72–8. https://doi.org/10.1016/j.preghy.2018.03.010. · DOI
  68. Umapathy A, Chamley LW, James JL. Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies. Angiogenesis. 2020;23(2):105–17. https://doi.org/10.1007/s10456-019-09694-w. · DOI
  69. Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016;27(2):71–8. https://doi.org/10.5830/CVJA-2016-009. · DOI
  70. Michita RT, V. de L. Kaminski, and J. A. B. Chies,. Genetic variants in preeclampsia: lessons from studies in Latin-American populations. Front Physiol. 2018;9:1771. https://doi.org/10.3389/fphys.2018.01771. · DOI
  71. De Kat AC, Hirst J, Woodward M, Kennedy S, Peters SA. Prediction models for preeclampsia: a systematic review. Pregnancy Hypertens. 2019;16:48–66. https://doi.org/10.1016/j.preghy.2019.03.005. · DOI
  72. Marić I, et al. Early prediction of preeclampsia via machine learning. Am J Obstet Gynecol MFM. 2020;2(2): 100100. https://doi.org/10.1016/j.ajogmf.2020.100100. · DOI
  73. Wright D, et al. Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol. 2019;220(2):199.e1-199.e13. https://doi.org/10.1016/j.ajog.2018.11.1087. · DOI
  74. Firoz T, Sanghvi H, Merialdi M, Von Dadelszen P. Pre-eclampsia in low and middle income countries. Best Pract Res Clin Obstet Gynaecol. 2011;25:4537–48. https://doi.org/10.1016/j.bpobgyn.2011.04.002 (Bailliere Tindall Ltd). · DOI
  75. Wright D, Wright A, Nicolaides KH. The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol. 2020;223(1):12–23. https://doi.org/10.1016/j.ajog.2019.11.1247. · DOI
  76. McSpedon C. Reproductive care during COVID-19. Am J Nurs. 2020;120(9):19–20. https://doi.org/10.1097/01.NAJ.0000697600.29112.22. · DOI
  77. McLaren ZM, et al. Cost effectiveness of medical devices to diagnose pre-eclampsia in low-resource settings. Dev Eng. 2017;2:99–106. https://doi.org/10.1016/j.deveng.2017.06.002. · DOI
  78. Majors CE, Smith CA, Natoli ME, Kundrod KA, Richards-Kortum R. Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings. Lab Chip. 2017;17(20):3351–87. https://doi.org/10.1039/c7lc00374a. · DOI
  79. Nathan HL, et al. The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settings. Reprod Health. 2018;15(1):5. https://doi.org/10.1186/s12978-017-0450-y. · DOI · Paper page
  80. Magee LA, Khalil A, von Dadelszen P. Pregnancy hypertension diagnosis and care in COVID-19 era and beyond. Ultrasound Obstet Gynecol. 2020;56(1):7–10. https://doi.org/10.1002/uog.22115. · DOI
  81. Stewart KA, et al. Trends in ultrasound use in low and middle income countries: a systematic review. Int J MCH AIDS. 2020;9(1):103–20. https://doi.org/10.21106/ijma.294. · DOI
  82. Hurrell A, Beardmore-Gray A, Duhig K, Webster L, Chappell L, Shennan A. Placental growth factor in suspected preterm pre-eclampsia: a review of the evidence and practicalities of implementation. BJOG An Int J Obstet Gynaecol. 2020;16425(1471–0528):2020. https://doi.org/10.1111/1471-0528.16425. · DOI
  83. Grauer GF. Proteinuria: measurement and interpretation. Top Companion Anim Med. 2011;26(3):121–7. https://doi.org/10.1053/j.tcam.2011.04.002. · DOI
  84. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46(3):205–17. https://doi.org/10.1258/acb.2009.009007. · DOI
  85. Buhimschi IA, et al. Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci Transl Med. 2014;6(245):245ra92-245ra92. https://doi.org/10.1126/scitranslmed.3008808. · DOI
  86. Steegers EAP, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631–44. https://doi.org/10.1016/S0140-6736(10)60279-6. · DOI · Paper page
  87. De Oliveira L, et al. Creating biobanks in low and middle-income countries to improve knowledge – the PREPARE initiative. Pregnancy Hypertens. 2018;13:62–4. https://doi.org/10.1016/j.preghy.2018.05.007. · DOI
  88. Giachini FR, et al. Vascular dysfunction in mother and offspring during preeclampsia: contributions from Latin-American Countries. Curr Hypertens Rep. 2017;19(10):83. https://doi.org/10.1007/s11906-017-0781-7 (Current Medicine Group LLC 1). · DOI
  89. Conde-Agudelo A, Belizán JM. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG An Int J Obstet Gynaecol. 2000;107(1):75–83. https://doi.org/10.1111/j.1471-0528.2000.tb11582.x. · DOI · Paper page
  90. Rambaldi MP, Weiner E, Mecacci F, Bar J, Petraglia F. Immunomodulation and preeclampsia. Best Pract Res Clin Obstet Gynaecol. 2019;60:87–96. https://doi.org/10.1016/j.bpobgyn.2019.06.005. · DOI
  91. Askelund KJ, Chamley LW. Trophoblast deportation part I: review of the evidence demonstrating trophoblast shedding and deportation during human pregnancy. Placenta. 2011;32(10):716–23. https://doi.org/10.1016/j.placenta.2011.07.081. · DOI
  92. Ganapathy R, Ayling LJ, Whitley GSJ, Cartwright JE, Thilaganathan B. Effect of first-trimester serum from pregnant women with high-resistance uterine artery Doppler resistance on extravillous trophoblast invasion. Hum Reprod. 2006;21(5):1295–8. https://doi.org/10.1093/humrep/dei482. · DOI
  93. Kalkunte S, et al. Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am J Pathol. 2010;177(5):2387–98. https://doi.org/10.2353/ajpath.2010.100475. · DOI
  94. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approaches for a multifactorial disease. DMM Dis Model Mech. 2012;5(1):9–18. https://doi.org/10.1242/dmm.008516. · DOI
  95. Garcia PJ, You P, Fridley G, Mabey D, Peeling R. Point-of-care diagnostic tests for low-resource settings. Lancet Glob Heal. 2015;3(5):e257–8. https://doi.org/10.1016/S2214-109X(15)70089-6. · DOI
  96. Da Broi MG, Giorgi VSI, Wang F, Keefe DL, Albertini D, Navarro PA. Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. J Assist Reprod Genet. 2018;35(5):735–51. https://doi.org/10.1007/s10815-018-1143-3. · DOI · Paper page
  97. Tarca AL, et al. Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study. J Matern Neonatal Med. 2020. https://doi.org/10.1080/14767058.2019.1685964. · DOI
  98. Breathett K, Muhlestein D, Foraker R, Gulati M. Differences in preeclampsia rates between African American and Caucasian women: trends from the national hospital discharge survey. J Women’s Heal. 2014;23(11):886–93. https://doi.org/10.1089/jwh.2014.4749. · DOI
  99. Lee LJ, et al. Role of maternal occupational physical activity and psychosocial stressors on adverse birth outcomes. Occup Environ Med. 2017;74(3):192–9. https://doi.org/10.1136/oemed-2016-103715. · DOI
  100. Giurgescu C, Misra DP. Psychosocial factors and preterm birth among black mothers and fathers, MCN. Am J Matern Nurs. 2018;43(5):245–51. https://doi.org/10.1097/NMC.0000000000000458. · DOI
  101. Giurgescu C, et al. Relationships among psychosocial factors, biomarkers, preeclampsia, and preterm birth in African American women: A pilot. Appl Nurs Res. 2015;28(1):e1–6. https://doi.org/10.1016/j.apnr.2014.09.002. · DOI
  102. Hardeman RR, Murphy KA, Karbeah J, Kozhimannil KB. Naming institutionalized racism in the public health literature: a systematic literature review. Public Health Rep. 2018;133(3):240. https://doi.org/10.1177/0033354918760574. · DOI
  103. Sheets L, Johnson J, Todd T, Perkins T, Gu C, Rau M. Unsupported labeling of race as a risk factor for certain diseases in a widely used medical textbook. Acad Med. 2011;86(10):1300–3. https://doi.org/10.1097/ACM.0b013e31822bbdb5. · DOI
  104. Geronimus AT. The weathering hypothesis and the health of African-American women and infants: evidence and speculations. Ethn Dis.1992;2(3):207–221. https://europepmc.org/article/med/1467758. Accessed 23 Nov 2020.
  105. Roeder A. America is Failing its Black Mothers | Harvard Public Health Magazine | Harvard T.H. Chan School of Public Health. Magazine of the Harvard T.H: Chan School of Public Health; 2019.
  106. Walker R, Williams J, Egede L. Impact of race/ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci. 2016;35(4):366–73. https://doi.org/10.1016/j.amjms.2016.01.008.Impact. · DOI
  107. Hanson M. The inheritance of cardiovascular disease risk. Acta Paediatr. 2019;108(10):1747–56. https://doi.org/10.1111/apa.14813. · DOI
  108. Sullivan S. Inheriting Racist disparities in health: epigenetics and the transgenerational effects of white racism. Crit Philos Race. 2013;1(2):190–218. · DOI
  109. Gong J, Savitz DA, Stein CR, Engel SM. Maternal ethnicity and pre-eclampsia in New York City, 1995–2003. Paediatr Perinat Epidemiol. 2012;26(1):45–52. https://doi.org/10.1111/j.1365-3016.2011.01222.x. · DOI
  110. Cripe SM, O’Brien W, Gelaye B, Williams MA. Perinatal outcomes of Southeast Asians with pregnancies complicated by gestational diabetes mellitus or preeclampsia. J Immigr Minor Heal. 2012;14(5):747–53. https://doi.org/10.1007/s10903-011-9537-7. · DOI
  111. Flegal KM, et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr. 2009;89(2):500–8. https://doi.org/10.3945/ajcn.2008.26847. · DOI · Paper page
  112. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev. 2001;2(3):141–7. https://doi.org/10.1046/j.1467-789x.2001.00031.x. · DOI
  113. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701. https://doi.org/10.1093/ajcn/72.3.694. · DOI · Paper page
  114. Humphreys S. The unethical use of BMI in contemporary general practice. Br J Gen Pract. 2010;60(578):696–7. https://doi.org/10.3399/bjgp10X515548. · DOI
  115. Foo FL, et al. Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restriction. Hypertension. 2018;72(2):442–50. https://doi.org/10.1161/HYPERTENSIONAHA.118.11092. · DOI
  116. Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014;38(3):139–45. https://doi.org/10.1038/jid.2014.371. · DOI · Paper page
  117. Williams D, Davison J. Pregnancy plus: chronic kidney disease in pregnancy. BMJ. 2008;336(7637):211–5. https://doi.org/10.1136/bmj.39406.652986.BE (BMJ Publishing Group). · DOI
  118. Odell CD, et al. Maternal hypertension as a risk factor for low birth weight infants: comparison of Haitian and African-American women. Matern Child Health J. 2006;10(1):39–46. https://doi.org/10.1007/s10995-005-0026-2. · DOI

Cited by

See all 23

Metadata

Authors
Lee, K., Brayboy, L., & Tripathi, A.
Venue
Regenerative Engineering and Translational Medicine
Publisher
Springer Science and Business Media LLC
Published
2022-05-10
Volume
8
Issue
3
Pages
394-406
ISSN
  • 2364-4133
  • 2364-4141
DOI
10.1007/s40883-021-00243-w
Cited by
23
References
8
Language
en
Licence
Funders
  • National Institute of General Medical Sciences (R25GM083270)
  • National Science Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.